SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Market Cap	2.28B
Revenue (ttm)	986.21M
Net Income (ttm)	146.45M
Shares Out	150.61M
EPS (ttm)	0.97
PE Ratio	15.61
Forward PE	15.92
Dividend	0.16 (1.06%)
Ex-Dividend Date	Feb 4, 2026

Volume	166,918
Average Volume	99,868
Open	15.04
Previous Close	15.10
Day's Range	14.94 - 15.42
52-Week Range	14.94 - 30.25
Beta	1.11
RSI	23.42
Earnings Date	Dec 11, 2025

About ETR:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 1SXP

Financial Performance

In 2025, ETR:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.